Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Nature Cancer
|
February 5, 2022
Envisioning the future of precision oncology trials
Subha Madhavan, Robert A Beckman, Matthew D McCoy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 15, 2025
A Proof-of-Concept Clinical Trial Design for Evolutionary Guided Precision Medicine for Cancer
Deepak Parashar, Wei He, Peter Mon, et al.
Frontiers in Artificial Intelligence
|
November 29, 2023
Understanding the need for digital twins' data in patient advocacy and forecasting oncology
Hung-Ching Chang, Antony M Gitau, Siri Kothapalli, et al.
Stem Cells Translational Medicine
|
March 12, 2026
Towards evolutionary guided precision medicine of acute myeloid leukemia and Fanconi anemia associated bone marrow failure
Robert A Beckman, Pamela S Becker, Julia Gallini, et al.
Biorxiv : the Preprint Server for Biology
|
September 4, 2023
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer
Shaymaa Bahnassy, Hillary Stires, Lu Jin, et al.
Endocrinology
|
October 28, 2023
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer
Shaymaa Bahnassy, Hillary Stires, Lu Jin, et al.
Journal of Medicinal Chemistry
|
December 22, 2025
PEGASUS: Unlocking Polarity in Cell-Permeable Cyclic Peptides Using AI Models Built on Massively Parallel Biological Assays
Cole Baker, Francis A Acquah, Lakshmi G Chivukula, et al.
Molecular and Cellular Biology
|
June 15, 2022
The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Adenocarcinoma
Samantha Z Brown, Grace A McCarthy, James R Carroll, et al.
Gastroenterology
|
December 11, 2020
Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice
Ivana Peran, Sivanesan Dakshanamurthy, Matthew D McCoy, et al.
Molecular Cancer Therapeutics
|
August 20, 2021
The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria
Christopher W Schultz, Grace A McCarthy, Teena Nerwal, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Nature Cancer
|
February 5, 2022
Envisioning the future of precision oncology trials
Subha Madhavan, Robert A Beckman, Matthew D McCoy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 15, 2025
A Proof-of-Concept Clinical Trial Design for Evolutionary Guided Precision Medicine for Cancer
Deepak Parashar, Wei He, Peter Mon, et al.
Frontiers in Artificial Intelligence
|
November 29, 2023
Understanding the need for digital twins' data in patient advocacy and forecasting oncology
Hung-Ching Chang, Antony M Gitau, Siri Kothapalli, et al.
Stem Cells Translational Medicine
|
March 12, 2026
Towards evolutionary guided precision medicine of acute myeloid leukemia and Fanconi anemia associated bone marrow failure
Robert A Beckman, Pamela S Becker, Julia Gallini, et al.
Biorxiv : the Preprint Server for Biology
|
September 4, 2023
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer
Shaymaa Bahnassy, Hillary Stires, Lu Jin, et al.
Endocrinology
|
October 28, 2023
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer
Shaymaa Bahnassy, Hillary Stires, Lu Jin, et al.
Journal of Medicinal Chemistry
|
December 22, 2025
PEGASUS: Unlocking Polarity in Cell-Permeable Cyclic Peptides Using AI Models Built on Massively Parallel Biological Assays
Cole Baker, Francis A Acquah, Lakshmi G Chivukula, et al.
Molecular and Cellular Biology
|
June 15, 2022
The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Adenocarcinoma
Samantha Z Brown, Grace A McCarthy, James R Carroll, et al.
Gastroenterology
|
December 11, 2020
Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice
Ivana Peran, Sivanesan Dakshanamurthy, Matthew D McCoy, et al.
Molecular Cancer Therapeutics
|
August 20, 2021
The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria
Christopher W Schultz, Grace A McCarthy, Teena Nerwal, et al.
Page
of 3